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TUMOURSAREKNOWN to contain hypoxic
cells that are resistant to treatment with
radiation. Hypoxic cells in solid tumours
might also be resistant to some drugs
because they are situated in regions of low
drug concentration, because their rate of
proliferation is low (Tannock, 1.968, 1970;
Hirst & Denekamp, 1979) or because
oxygen is required for drug uptake or
activity. Conversely, some drugs may have
selective toxicity for hypoxic cells (Mo-
hindra & Rauth, 1976; Song et al., 1976;
Stratford et al., 1980) and might be used
therapeutically in combination with radia-
tion or other drugs that tend to spare
hypoxic cells. We describe below the
in vitro effects of 5 anti-cancer drugs on
aerobic and hypoxic Chinese hamster
ovary (CHO) cells.
CHO cells are maintained in our labora-
tory in continuous suspension culture in
complete a-medium (Stanners et al., 1971)
supplemented with antibiotics and 10%
foetal calfserum (FCS). Cells were exposed
to air or N2 at a concentration of 5 x 105
cells/ml by the method of Mohindra &
Rauth (1976). Medium and cells in a
volume of 8 ml were stirred continuously
in small glass vials at 370C, and the
humidified gas mixture flowed through
inlet and outlet tubes which penetrated
the stoppers of each vial. Gas mixtures
were air/500 CO2 or N2/.5% CO2 (less than
10 ptS/106 02) and a flow rate of 1-2
cubic feet/h/vial was used. V'ials were
A(eptedl 1 .i (Octobu 1 98()
gassed for 90 min before adding drugs, to
allow equilibration ofthe medium with the
applied gas mixture (Mohindra & Rauith,
1976).
Druigs were diluted in 1 ml medium, an(d
added to the vials by a syringe with a
long needle that was passed through the
outlet tube. The response of the cells to
active metabolites of cyclophosphamide
was assessed by exposing them to 05a ml
serum taken from mice that were injected
with 200 mg/kg cyclophosphamide 30 min
before. At appropriate times, cells were
removed from the vials by syringe or
micropipette. Cells were washed, re-
suspended in a-medium + 10% FCS and
counted with a Coulter Counter. Appro-
priate dilutions were plated in triplicate,
and colonies were stained and counted
about 9 days later. Relative survival was
expressed as the ratio ofnumber ofcolonies
from drug-treated cultures to that from
control cultures that had received the
same gas exposure. All experiments were
repeated to ensure reproducibility.
Results of the experiments are shown in
Figs 1-3. Plating efficiency (PE) of
aerobic cells was usually in the range
70-90%o. PE of hypoxic cells decreased
slowly with time and was typically
40-50 o after 8 h exposture.
There were no differences in sensitivitv
of CHO cells to 1,3-bis(2-chlorethyl 1)-
1-nitrosourea (BCNU) or cis-dichloro-
diammine platintim II (cis-Pt) tinder
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FiG. 1.. Relative survival of aerobic (open
symbols) and hypoxic (closed symbols)
CHO cells to BCNU and cs8-Pt. Cells were
exposed to variable drug concentration for
a fixed time (4 h) or to a constant drug
concentration for variable times. Mean and
range for triplicate plates are plotted.
aerobic and hypoxic conditions (Fig. 1).
Results for cis-Pt may be cell-line-
dependent, since Stratford et al. (1980)
have reported increased toxicity of ci8-Pt
for hypoxic V79-379A cells. Active meta-
bolites of cyclophosphamide have similar
sensitivity for aerobic and hypoxic CHO
cells, but bleomycin is more toxic in air
(Fig. 2). Adriamycin has higher toxicity
in air (Fig. 3) though differences in sensi-
tivity are small compared to those repor-
ted for radiation. Results for Adriamycin
and bleomycin are consistent with those
of other investigators who have exposed
different cell lines to similar periods of
hypoxia (Roizin-Towle & Hall, 1978;
Martin & McNally, 1979; Smith et al.,
1979).
In two experiments, we assayed the
effect of prior exposure of CHO cells to
hypoxia on the subsequent response to
Adriamycin in air; these experiments
were suggested by the results of Smith et
al. (1979), who reported a protective effect
of prior hypoxia. We exposed cells to air
or N2 for 8 h or 17 5 h, then changed the
gas mixture air-÷N2, or N2-- air, of half
the samples. Drug was added 1 h later
and cells were washed and plated after an
exposure of 4 h. Results were qualitatively
similar in the two experiments and con-
firmed that hypoxia protected against
subsequent drug exposure in air; the pro-
tection was greater with a longer period
(17-5 h) of prior exposure, and results of
this experiment are shown in the Table.
Since we found, at most, small differen-
ces in sensitivity of aerobic and hypoxic
cells to the 5 drugs tested, we have not
undertaken a detailed study ofmechanism.
We measured uptake of [3H]-dT of CHO
cells after 4 h exposure to air or N2 by
scintillation counting, andfound anuptake
of 0-48 and 0 45 for hypoxic cells relative
to aerobic cells in 2 experiments. The
lower proliferation of hypoxic cells is a
possible cause of their decreased sensi-
tivity to Adriamycin and bleomycin.
In the present experiments CHO cells
were exposed to drugs in vitro under
hypoxic but otherwise rather ideal condi-
tions of nutrition. The drug sensitivity of
hypoxic cells in solid tumours depends on
more complex factors. Differences of pro-
liferative rate of aerobic and chronically
hypoxic cells in tumours may be greater
than in the current in vitro experiments
(Tannock, 1968, 1970) and both cell pro-
liferation and drug sensitivity are un-
doubtedly influenced by other nutritional
factors in vivo. Also, chronically hypoxic
cells in tumours are situated at greater
distances from patent blood vessels than
are aerobic cells, so that the drug concen-
tration that can be achieved in their
vicinity may be low. Ozols etal. (1979)have
demonstrated decreased uptake of Adria-
mycin as measured by fluorescence of cells
near necrotic regions ofsolid tumours, and
Sutherland et al. (1979) reported a similar
decreasing gradient ofAdriamycin fluores-
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FIG. 2.-Relative survival of aerobic (open symbols) and hypoxic (closed symbols) CHO cells to
bleomycin and to serum from mice that had received cyclophosphamide. Mean and range for
triplicate plates are plotted.
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FIG. 3.-Relative survival of aerobic (open symbols) and hypoxic (closed symbols) CHO cells to
Adriamycin. Cells were exposed to variable drug concentration for afixed time (4 h) or to a constant
drug concentration (1 ,ug/ml) for variable times. Mean and range for triplicate plates are plotted.
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TABLE.-Plating efficiency (PE) of CHO
cells exposed to air or N2 (+5°% C02)
for 17-5 h and then exposed for 4 h to




Air-+Air < 10-4 0 76 < 10-4
Air-+N2 6-4 x 10-4 0-71 9.0 x 10-4
N2-+Air 4-2x 10-4 0-34 1 2x l0-3
N2-+N2 1-8x 10-4 0-11 1-7 x10-3
cenceintheinteriorofmulti-cell spheroids.
We have not seen marked differences in
fluorescence of aerobic and hypoxic CHO
cells after exposure to Adriamycin in vitro,
but low concentration of the drug in
hypoxic and poorly nourished cells in
vivo might be an important cause of drug
resistance. Assessment of survival of
hypoxic and aerobic tumour cells following
drugtreatmentwithAdriamycin and other
drugs in vivo deserves high priority.
This work was supported by a research grant from
the National Cancer Institute of Canada.
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